CMS Moratorium on Hospice & Home Health: What Providers Need to Know
The recent CMS announcement of a six-month moratorium on Medicare enrollment for hospice and home health providers marks one of the most significant regulatory shifts in the post-acute care landscape in recent years. Although CMS frames it as a temporary measure, it extends beyond an enrollment pause and actively reshapes growth strategy, compliance expectations, and transaction activity nationwide.
In a recent industry discussion hosted by SimiTree and AGG, leaders in consulting, compliance, data analytics, and healthcare law examined the policy’s drivers and outlined what providers should expect in the months ahead.
A Nationwide Policy with Industry-Wide Impact
CMS has temporarily suspended new Medicare enrollment for hospice and home health providers across all 50 states. CMS states that it aims to address rapid program growth and rising concerns about fraud, waste, and abuse in select regions.
However, the policy’s broad scope shows that CMS is not targeting isolated issues. Instead, CMS signals a broader shift toward increased federal oversight of post-acute care.
Industry leaders emphasized that the moratorium does not only affect new entrants. It also disrupts organizations pursuing de novo expansion, providers in the enrollment pipeline, and companies evaluating acquisition strategies.
Access to Care and Market Pressure
Participants in the discussion raised concerns about access to care.
Hospice and home health markets already face uneven provider distribution, workforce shortages, and rising demand driven by an aging population. By restricting new entrants, the moratorium may widen existing gaps in care — especially in underserved or high-growth regions.
In practice, this pressure may:
- Strain existing providers
- Extend hospital stays and delay discharges
- Reduce home-based service availability in certain regions
- Increase pressure on payer networks and referral systems
While CMS designs enforcement actions to protect program integrity, stakeholders stressed the need to balance oversight with patient access.
Compliance Enforcement Expands Nationwide
The policy shift immediately increases regulatory scrutiny.
Providers are already experiencing more frequent audits, including RAC and TPE reviews, along with broader enforcement activity in high-growth states. Although regulators initially concentrate efforts in states such as California, industry expectations indicate that oversight will expand nationwide.
CMS is focusing on several compliance areas:
- Hospice eligibility and length-of-stay documentation
- Live discharge patterns
- Home health medical necessity and homebound status
- Billing accuracy and pre-payment review readiness
The current environment sends a clear message: providers must embed compliance into daily operations rather than treat it as a reactive function.
Implications for M&A Strategy
With de novo expansion constrained, the healthcare services market is shifting further toward mergers and acquisitions as the primary growth path. However, deal activity is becoming more complex.
Buyers now apply stricter standards during diligence and closely evaluate compliance risk, clinical documentation, billing integrity, and audit history. These factors increasingly influence valuation and deal structure.
Key trends include:
- Increased scrutiny of compliance history during diligence
- Greater use of equity-based transaction structures in some cases
- Higher risk adjustments in pricing models
- Greater emphasis on clean clinical and financial records
Rather than slowing activity, the moratorium accelerates consolidation, particularly among smaller providers seeking scale or exit opportunities.
Operational Strategy: Strengthening Core Markets
With growth constrained, providers shift focus from expansion to operational performance.
High-performing organizations strengthen their core markets by:
- Deepening referral relationships
- Enhancing payer contracting strategies
- Improving quality metrics and outcomes
- Optimizing care transitions across service lines
- Addressing workforce recruitment and retention
A central theme emerges: providers must strengthen existing operations before pursuing expansion or acquisitions.
The Role of Data and Market Intelligence
As expansion options narrow, organizations increasingly rely on data-driven decision-making for strategy.
Providers evaluate markets based on:
- Regulatory intensity and enforcement activity
- Patient population size and growth
- Medicare and Medicare Advantage utilization trends
- Workforce availability and stability
- Competitive density and referral dynamics
This approach helps organizations assess both opportunity and risk before deploying capital or pursuing acquisitions.
Looking Ahead: A Prolonged Period of Oversight
Although CMS defines the moratorium as a six-month policy, historical precedent shows that similar actions often extend beyond their initial timeframe.
Industry consensus suggests that:
- The policy may extend beyond six months
- Regulatory oversight will likely remain elevated
- CMS may introduce additional enforcement tools
- Enforcement intensity may vary by region and risk profile
Providers must therefore plan for sustained regulatory pressure rather than a temporary disruption.
Strategic Takeaways for Providers
Providers are prioritizing several key strategies:
- Plan for sustained oversight: Organizations assume regulatory pressure will continue rather than dissipate.
- Strengthen compliance infrastructure: Internal audits, documentation integrity, and eligibility validation become essential safeguards.
- Prepare for a more selective M&A environment: Due diligence standards tighten, and compliance risk increasingly affects valuation.
- Focus on operational excellence: Referral networks, payer relationships, staffing stability, and quality performance drive differentiation.
- Use data to guide growth decisions: Market selection now requires integrating both opportunity and regulatory risk.
Final Perspective
The CMS moratorium represents a pivotal shift for the hospice and home health industry. While CMS designed it to address program integrity concerns, it effectively restructures how providers grow, compete, and transact.
In the near term, the industry will likely experience increased consolidation, heightened compliance scrutiny, and greater emphasis on operational discipline. Providers that proactively invest in compliance readiness, data-driven strategy, and core market strength will be best positioned to navigate this new regulatory environment.
SimiTree continues to support hospice and home health organizations with compliance guidance, operational strategy, and data-driven insights as they adapt to this evolving landscape.